Novartis Sounds Alarm On Global Trade Policy

 
• By Mary Jo Laffler
  
Novartis criticized many of the elements of its MFN deal weeks after announcing it. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from United States